{"id":58428,"date":"2016-04-13T12:17:21","date_gmt":"2016-04-13T16:17:21","guid":{"rendered":"http:\/\/www.bu.edu\/experts\/?post_type=profile&#038;p=58428"},"modified":"2019-10-09T09:25:51","modified_gmt":"2019-10-09T13:25:51","slug":"tsuneyaikezu","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/prsocial\/profile\/tsuneyaikezu\/","title":{"rendered":"Tsuneya Ikezu"},"content":{"rendered":"<p>Tsuneya<span class=\"Apple-tab-span\"> <\/span>Ikezu is a professor in BU School of Medicine&#8217;s Departments of Pharmacology &amp; Experimental Therapeutics and Neurology. He is also part of BU MED&#8217;s\u00a0<span>Alzheimer\u2019s<\/span>\u00a0Disease Center.<\/p>\n<p>Dr. Ikezu\u2019s research interests are focused on the role of neuroinflammation in the pathophysiology of dementia and as a potential therapeutic target of Alzheimer\u2019s disease, HIV-associated dementia, and more recently chronic traumatic encephalopathy and encephalomyelopathy. He also studies enzymes that induce phosphorylation and aggregation of neurological disease-associated proteins, such as Alzheimer\u2019s disease, HIV-associated dementia, and frontotemporal dementia.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"author":11144,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/58428"}],"collection":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/users\/11144"}],"version-history":[{"count":2,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/58428\/revisions"}],"predecessor-version":[{"id":70144,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/58428\/revisions\/70144"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/media?parent=58428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}